SCHEMBL2127225

SCHEMBL2127225

O=P(O)(O)Oc1ccccc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
INPPL1 O15357 7/20 0.57
INPP5A Q14642 5/20 0.57
INPP5B P32019 2/20 0.57
SRC P12931 2/20 0.55
HPGD P15428 2/20 0.55
KDM4E B2RXH2 1/20 0.55
USP2 O75604 1/20 0.55
ALDH1A1 P00352 1/20 0.55
PDE3A Q14432 1/20 0.55
HSD17B10 Q99714 1/20 0.55
AKT1 P31749 1/20 0.50
PTK2B Q14289 1/20 0.49
MAPK1 P28482 1/20 0.45
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29188656 0.98 LMNA (0.62) LMNASMN1; SMN2INPPL1INPP5AINPP5B
SCHEMBL2472082 0.87 SMN1; SMN2 (0.64) LMNASMN1; SMN2INPPL1INPP5AINPP5B
SCHEMBL30557968 0.87 SMN1; SMN2 (0.64) LMNASMN1; SMN2INPPL1INPP5AINPP5B
SCHEMBL28854947 0.86 LMNA (0.50) LMNASMN1; SMN2INPPL1INPP5AINPP5B
SCHEMBL9492467 0.85 SMN1; SMN2 (0.62) LMNASMN1; SMN2INPPL1INPP5AINPP5B
Tromethamine SCHEMBL284296 0.85 LMNA (0.53) LMNASMN1; SMN2INPPL1INPP5AINPP5B
SCHEMBL9493718 0.84 SMN1; SMN2 (0.56) LMNASMN1; SMN2INPPL1INPP5AINPP5B
SCHEMBL2573126 0.84 INPPL1 (0.70) INPPL1INPP5AINPP5BSRCHPGD
SCHEMBL28853887 0.83 SMN1; SMN2 (0.60) LMNASMN1; SMN2INPPL1INPP5AINPP5B
SCHEMBL557291 0.83 INPPL1 (0.59) LMNASMN1; SMN2INPPL1INPP5AINPP5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024020507-A2 ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF JAL THERAPEUTICS, LLC (US) 2024-01-25 WO claimed
EP-2647617-B1 NUCLEOSIDE ANALOG OR SALT THEREOF, OLIGONUCLEOTIDE ANALOG, GENE EXPRESSION INHIBITOR, AND NUCLEIC-ACID PROBE FOR DETECTING GENE JAPAN SCIENCE & TECH AGENCY (JP) 2016-07-13 EP claimed
CN-103237780-B Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic acid probe for detecting gene JAPAN SCIENCE & TECH AGENCY 2015-03-04 CN claimed
US-8865898-B2 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-10-21 US claimed
US-20140221637-A1 NUCLEOSIDE ANALOG OR SALT THEREOF, OLIGONUCLEOTIDE ANALOG, GENE EXPRESSION INHIBITOR, AND NUCLEIC-ACID PROBE FOR DETECTING GENE JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-08-07 US claimed
EP-2647617-A1 NUCLEOSIDE ANALOG OR SALT THEREOF, OLIGONUCLEOTIDE ANALOG, GENE EXPRESSION INHIBITOR, AND NUCLEIC-ACID PROBE FOR DETECTING GENE Japan Science And Technology Agency (JP) 2013-10-09 EP claimed
EP-2354148-B1 Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof IMANISHI TAKESHI (JP) 2013-09-04 EP claimed
CN-103237780-A Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-cid probe for detecting gene JAPAN SCIENCE & TECH AGENCY 2013-08-07 CN claimed
EP-1661905-B9 NOVEL ARTIFICIAL NUCLEIC ACIDS OF N-O BOND CROSSLINKAGE TYPE IMANISHI TAKESHI (JP) 2012-12-19 EP claimed
EP-1661905-B1 NOVEL ARTIFICIAL NUCLEIC ACIDS OF N-O BOND CROSSLINKAGE TYPE IMANISHI TAKESHI (JP) 2012-04-25 EP claimed
US-5594121-A DETECT VIRUSES, DISEASES GILEAD SCIENCES, INC. (US) 1997-01-14 US claimed
EP-0695306-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PURINES GILEAD SCIENCES, INC. (US) 1996-02-07 EP claimed
EP-0637965-A4 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES. GILEAD SCIENCES INC (US) 1996-01-24 EP claimed
US-5403503-A Containing a mixture of polyoxyalkylene glycol, polyester, phosphate and(or) phosphite IDEMITSU KOSAN CO., LTD. (JP) 1995-04-04 US claimed
EP-0637965-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1995-02-15 EP claimed
EP-0616612-A4 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE. GILEAD SCIENCES INC (US) 1995-01-11 EP claimed
WO-1994024144-A2 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PURINES GILEAD SCIENCES, INC. (US) 1994-10-27 WO claimed
EP-0616612-A1 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE GILEAD SCIENCES, INC. (US) 1994-09-28 EP claimed
WO-1993012135-A1 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE GILEAD SCIENCES, INC. (US) 1993-06-24 WO claimed
WO-1993010820-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1993-06-10 WO claimed